Some peripheral pharmacological characteristics of benzoctamine.
D000109:Acetylcholine / Q000037:antagonists & inhibitors; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000707:Anaphylaxis / Q000517:prevention & control; D000818:Animals; D000873:Anthracenes / Q000008:administration & dosage / Q000494:pharmacology*; D001095:Arachidonic Acids / Q000037:antagonists & inhibitors; D001920:Bradykinin / Q000037:antagonists & inhibitors; D002707:Chlordiazepoxide / Q000494:pharmacology; D002746:Chlorpromazine / Q000494:pharmacology; D003975:Diazepam / Q000627:therapeutic use; D004837:Epinephrine / Q000037:antagonists & inhibitors; D006168:Guinea Pigs; D006634:Histamine H1 Antagonists / Q000494:pharmacology; D007545:Isoproterenol / Q000037:antagonists & inhibitors; D008297:Male; D008635:Mescaline / Q000037:antagonists & inhibitors; D051379:Mice; D009538:Nicotine / Q000037:antagonists & inhibitors; D009638:Norepinephrine / Q000037:antagonists & inhibitors; D012702:Serotonin Antagonists; D013045:Species Specificity; D013565:Sympatholytics / Q000494:pharmacology; D014149:Tranquilizing Agents / Q000494:pharmacology*
D000317:Adrenergic alpha-Antagonists; D000873:Anthracenes; D001095:Arachidonic Acids; D006634:Histamine H1 Antagonists; D012702:Serotonin Antagonists; D013565:Sympatholytics; D014149:Tranquilizing Agents; D009538:Nicotine; D002707:Chlordiazepoxide; D007545:Isoproterenol; D000109:Acetylcholine; D003975:Diazepam; D008635:Mescaline; D001920:Bradykinin; D002746:Chlorpromazine; D009638:Norepinephrine; D004837:Epinephrine